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This issue of Interface Focus is a collection of papers on ‘The biomedical appli-
cations of graphene’. The idea to put together this theme issue evolved
during discussions between Prof. Peter N.T. Wells CBE, FREng, FMedSci,
FRS and myself in mid-2016. Very sadly, about a year ago, Prof. Wells
passed away. However, before that and even in the various last stages of
his life he was intensely involved in planning this theme issue with me.
I am deeply indebted to him for his contributions towards this and I dedicate
this theme issue to him as a memorial.1. Introduction
The very important role of graphene and graphene derivatives in science and
engineering is indisputable, but their significance in biomedicine is less clear
at the present time. In this theme issue, we aim to discuss this dilemma, illus-
trating areas of promise while identifying future challenges. In order to do this,
we have invited papers from authors from various disciplines and geographical
locations. Consequently, this issue is rich in the science, technology and engin-
eering of graphene in biomedicine, covering both the life and physical sciences,
engineering and medicine. Our authors come from the UK, the USA, Europe,
Australia and Asia and cover a wide variety of topics.
The first paper by Banerjee [1] reviews the current status very effectively. He
first discusses the unique properties of graphene and its derivatives and follows
this up with a wide-ranging discussion on recent progress in the applications of
graphene and its derivatives in several different areas of biomedicine. Sub-
sequently, the challenges involved in the use of these advanced materials in
biomedical applications are elucidated, and the future perspectives for their
use are discussed. The review provides an outlook on the new possibilities to
inspire broader interests across various biomedicine disciplines.
There is quite a lot of global discussion on whether graphene is a versatile
nano-platform for biomedical applications. Linklater et al. [2] in their paper
illustrate the processes involved in bactericidal mechanisms, which are not
well established at present. This is followed by a paper by Bugli et al. [3],
who illustrate that curcumin-loaded graphene derivatives can provide the
nano-morphology in fighting methicillin-resistant bacteria. Graphene oxide is
one of the most used and leading graphene derivatives and, in their paper,
Verre et al. [4] vividly demonstrate the effects of graphene oxide substrates in
increasing gene expression of biomolecules. The nano-platform is taken further
by Yang et al. [5], who are developing carbon (diamond)-coated nano-porous
membranes for cellular attachment.
Graphene quantum dots (GQDs) usually constitute a single to tens of layers
of graphene and are of a size less than a few tens of nanometres. Owing to their
exceptional properties, in particular biocompatibility, GQDs are considered to
be a novel material for biological applications. Their bioavailability in lung tis-
sues is demonstrated by Tabish et al. [6], and Justin & Chen [7] illustrate how
nano-composites containing GQDs can be used in drug delivery.
Biosensors are key assets when attempting the early diagnosis and monitor-
ing of disease. The recent advances in graphene-based materials for making
very sensitive and selective biosensor devices are vividly described by Szunerits
& Boukherroub [8]. Point-of-care devices for sensing diseases is very topical
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to renal cell carcinoma is illustrated in the paper by
Jakowiecki et al. [9].
The creation of novel science in relation to biomedicine
and graphene is of immense importance, but the translation
of these exciting developments into actual manufacturing is
also crucial in order to facilitate application. The paper by
De Sanctis et al. [10] attempts just that. These authors illus-
trate how novel routes of manufacturing, especially with
respect to patterning by functionalizing graphene-based
materials with different chemical entities, can be effective.In their paper, Matharu et al. [11] show how graphene can
be incorporated in polymers to manufacture fibres using a
novel gyratory technique, and elucidate how these are effec-
tive as anti-bacterial deposits. Kazantseva et al. [12] take the
topic of graphene-based fibres even further by showing
how networks of composite graphene–ceramic fibres can
be used in the control of stem cells.
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